Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 101 to 125 of 2013

TitleReference numberPublishedLast updated
Targeted muscle reinnervation for managing limb amputation painHTG750
Caesarean birthNG192
Linzagolix for treating symptoms of endometriosisTA1067
Efgartigimod for treating antibody-positive generalised myasthenia gravisTA1069
Headaches in over 12s: diagnosis and managementCG150
Somapacitan for treating growth hormone deficiency in people 3 to 17 yearsTA1066
Laparoscopic insertion of an inactive implant for gastro-oesophageal reflux diseaseHTG749
Tislelizumab for treating unresectable advanced oesophageal squamous cell cancer after platinum-based chemotherapy (terminated appraisal)TA1068
Nivolumab plus ipilimumab for untreated unresectable or metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA1065
Abortion careNG140
Dostarlimab with platinum-based chemotherapy for treating primary advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiencyTA1064
Capivasertib with fulvestrant for treating hormone receptor-positive HER2-negative advanced breast cancer after endocrine treatmentTA1063
Erdafitinib for treating unresectable or metastatic urothelial cancer with FGFR3 alterations after a PD-1 or PD-L1 inhibitorTA1062
Osimertinib with pemetrexed and platinum-based chemotherapy for untreated EGFR mutation-positive advanced non-small-cell lung cancerTA1060
Brentuximab vedotin in combination for untreated stage 3 or 4 CD30-positive Hodgkin lymphomaTA1059
Digital therapy for chronic tic disorders and Tourette syndrome: early value assessmentHTG748
Omaveloxolone for treating Friedreich's ataxia in people 16 years and over (terminated appraisal)TA1061
Drug-eluting stents for treating coronary artery disease: late-stage assessmentHTG747
COVID-19 rapid guideline: managing COVID-19NG191
Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19TA878
Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: early value assessmentHTG746
Slide sheets for moving or repositioning a person: late-stage assessmentHTG745
Falls: assessment and prevention in older people and in people 50 and over at higher riskNG249
Leniolisib for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and overHST33
Tislelizumab in combination for untreated advanced non-small-cell lung cancer (terminated appraisal)TA1058

Results per page

  1. 10
  2. 25
  3. 50
  4. All